Clinico-pathological pattern of extranodal non-Hodgkin's lymphoma in Saudi Arabia

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 12, 2011, Pages 3277-3282

  Abdul Rahman, Al Diab ^a,b   Aleem, Aamer ^a   Qayum, Abdul ^a   Al Askar, Ahmed S ^c   Ajarim, Dahish S ^d  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b Security Forces Hospital   (Saudi Arabia)

^c KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^d KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Clinico pathological pattern; Extranodal sites; Non hodgkin's lymphoma; Saudi arabia

Indexed keywords

ADULT; ARTICLE; BRAIN TUMOR; FEMALE; FOLLOW UP; GASTROINTESTINAL TUMOR; HEAD AND NECK TUMOR; HUMAN; INCIDENCE; LARGE CELL LYMPHOMA; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SAUDI ARABIA; SKIN TUMOR;

ADULT; BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SAUDI ARABIA; SKIN NEOPLASMS;

EID: 84864503950     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Abid MB, Nasim F, Anwar K, Pervez S (2005). Diffuse large B cell lymphoma (DLBCL) in Pakistan: an emerging epidemic? Asian Pac J Cancer Prev, 6, 531-4.
2. Ahmed M, Malik IA (1997). Non-Hodgkins lymphoma in developing countries. In Magrath IT (ed): The Non-Hodgkins Lymphomas (2nd edn), London. Arnold, 1031-54.
3. Al-Moagel MA, Evans DG, Abdulghani ME, et al (1990). Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saudia Arabia, and comparison of those with and without upper gastrointestinal symptoms. Am J Gastroenterol, 85, 944-8.
4. Al Shemmari SH, Ameen RM, Sajnani KP (2008). Extranodal lymphoma: a comparative study. Hematology, 13, 163-9.
5. Baar J, Burkes RL, Gospodarowicz M (1999). Primary non-Hodgkin's lymphoma of bone. Semin Oncol, 26, 270-5.
6. Banfi A, Bonadonna G, Carnevali G, et al (1968). Preferential sites of involvement and spread in malignant lymphomas. Eur J Cancer, 4, 319-24.
7. Burg G, Drummer R, Dommann S, et al (1995). Pathology of cutaneous T-cell lymphomas. Hematol Oncol Clin North Am, 9, 961-95.
8. Cancer Incidence Report, Saudi Cancer Registry, 1999-2000, and 2007.
9. Carbone PP, Kaplan HS, Musshoff K, et al (1971). Report of the committee on Hodgkins disease staging classification. Cancer Res, 31, 1860-1.
10. D'Amore F, Brincker H, Gronbaek K, et al (1994). Non-Hodgkin's lymphoma of the gastrointestinal tract. A population-based analysis of incidence, geographic distribution, clinicopathologic presentation features and prognosis. Danish Lymphoma Study Group. J Clin Oncol, 12, 1673-84.
11. D'Amore F, Christensen BE, Brincker H, et al (1991). Clinicopathologic features and prognostic factors in extranodal non-Hodgkins lymphomas. Danish LYFO Study Group. Eur J Cancer, 27, 1201-8.
12. De Camargo OP, Dos Santos Machado TM, Croci AT, et al (2002). Primary bone lymphoma in 24 patients treated between 1955 and 1999. Clin Orthop Relat Res, 397, 271-80.
13. Diamandidou E, Cohen PR, Kurzrock R (1996). Mycosis fungoides and Sezary syndrome. Blood, 88, 2385-409.
14. Doria R, Jekel JF, Cooper DL (1994). Thyroid lymphoma: The case for combined modality treatment. Cancer, 73, 200-6.
15. Ducreux M, Boutron MC, Piard F, Caril PM, Faivre J (1998). A 15 year series of gastrointestinal non-Hodgkins lymphoma: A population-based study. Br J Cancer, 77, 511-4.
16. Evans LS, Hancock BW (2003). Non-Hodgkins Lymphoma. Lancet, 362, 139-46.
17. Freeman C, Berg JW, Cutler SJ (1972). Occurrence and prognosis of extranodal lymphomas. Cancer, 29, 252-60.
18. Gurney KA, Cartwright RA (2002). Increasing incidence and descriptive epidemiology of extranodal non-Hodgkins lymphoma in parts of England and Wales. Hematol J, 3, 95-104.
19. Herrmann R, Panahon AM, Barcos M, et al (1980). Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer, 46, 215-22.
20. Ibrahim EM, Ezzat AA, El-Weshi AN, et al (2001). Primary intestinal diffuse large B-cell non-Hodgkin's lymphoma: Clinical features, management, and prognosis of 66 patients. Annal Oncol, 12, 53-8.
21. Jacobs C, Hoppe RT (1985). Non-Hodgkins lymphomas of head and neck extranodal sites. Intl J Rradiat Oncol Biol Phys, 11, 357-64.
22. Krol ADG, le Cessie S, Snijder S, et al (2003). Primary extranodal non-Hodgkins lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Annals Oncol, 14, 131-9.
23. Levine PH, Hoover RN (1992). The emerging epidemics of non-Hodgkin's lymphoma: Current knowledge regarding aetiologic factors. Cancer Res, 42, 5425-74.
24. Marie MA (2008). Seroprevalence of Helicobacter pylori infection in a large series of patients in an urban area of Saudi Arabia. Korean J Gastroenterol, 52, 226-9.
25. Møller MB, Pedersen NT, Christensen BE (2004). Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation-a population-based study of 1575 cases. Br J Haematol, 124, 151-9.
26. Morton JE, Leyland MJ, Hudson GV, et al (1993). Primary gastrointestinal non-Hodgkins lymphoma. A review of 175 British National Lymphoma Investigation cases. Br J Cancer, 67, 776-82.
27. Muller AM, Thorst G, Mertelsmann R, et al (2005). Epidemiology of non-Hodgkins lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol, 84, 1-12.
28. Papaxoinis G, Papageorgiou S, Rontogianni D, et al (2006). Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk Lymphoma, 47, 2140-6.
29. Paryani S, Hoppe RT, Burke JS, et al (1983). Extralymphatic involvement in diffuse non-Hodgkin's lymphoma. J Clin Oncol, 1, 682-8.
30. Rohatiner A (1994). Report on a workshop convened to discuss the pathological and staging classification of gastrointestinal tract lymphoma. Ann Oncol, 5, 397-400.
31. Rusinowska Z, Kozaczka A, Wojnar J, et al (1996). Primary forms of extralymphatic non-Hodgkin's lymphoma. Pol Tyg Lek, 51, 263-5.
32. Sutcliffe SB, Gospodarowicz MK (1992). Clinical features and management of localized extranodal lymphomas. In Keating A, Armittage J, Burnet A, Newland A (eds): Haematological Oncology, vol 2, Cambridge: Cambridge University Press, 189-223.
33. Temmim L, Baker H, Amanguno H, et al (2004). Clinicopathological features of extranodal lymphomas: Kuwait experience. Oncology, 67, 382-9.
34. The non-Hodgkin's lymphoma Classification Project (1997). A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood, 89, 3909-18.
35. Tsang RW, Gospodarowicz MK, Sutcliffe SB, et al (1993). Non-Hodgkins lymphoma of the thyroid gland: prognostic factors and treatment outcome. The Princess Margaret Hospital Lymphoma Group. Int J Radiat Oncol Biol Phys, 27, 599-604.
36. Williemze R, Jaffe ES, Burg G, et al, (2005). WHO-EORTC classification for cutaneous lymphomas. Blood, 105, 3768-85.
37. Zucca E, Roggero E, Bertoni F, Cavalh F (1997). Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Abdul Rahman Al Diab et al Asian Pacific Journal of Cancer Prevention, Vol 12, 2011 Ann Oncol, 8, 727-37.